The aim of this paper is to identify the stakeholders involved in the Health Technology Assessment (HTA) process with particular attention to their role and potential contribution from patients and citizens. Moreover, a focus on elements to be shared among stakeholders will be provided. These topics were discussed at the Health Policy Forum, an initiative promoted by the Italian Society of Health Technology Assessment (SIHTA) in partnership with other scientific societies. Manufacturers, regulators, institutions and citizens could talk freely under the ‘‘Chatham House Rules’’ in plenary sessions and subgroups, suggesting proposals on the issues addressed. Healthcare managers, policy makers, health providers, researchers, manufacturers, patients and the public were identified as main stakeholders. The contribution they provide to HTA process is closely related to their position within the ‘‘pertinence-relevance-weight matrix’’. All participants focused on the need of rigorous methods and measures of assessment. Finally, the potential contributions of citizens and patients are related to the time of involvement and their level of information. In conclusion, there is a growing awareness of the need of greater stakeholders’ involvement in defining methods, responsibilities, quality and timing of interactions in order to improve the impact of HTA in healthcare decision-making.
|Titolo tradotto del contributo||[Autom. eng. transl.] The role of stakeholders in the HTA process|
|Numero di pagine||9|
|Rivista||GIORNALE ITALIANO DI HEALTH TECHNOLOGY ASSESSMENT|
|Stato di pubblicazione||Pubblicato - 2011|
- health technology assessment